Natsume Tsugitaka | Aska Pharmaceutical Co. Ltd. Research & Development Division
スポンサーリンク
概要
関連著者
-
Watanabe Junichi
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Kobayashi Masatoshi
Department Of Anatomy & Histology Kurume University School Of Medicine
-
Kobayashi Makio
Dept. Of Pathology Tokyo Women's Medical University
-
Kobayashi Makio
東京女子医科大学 消化器内科学
-
Nakayama Takaharu
Medicinal Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Natsume Tsugitaka
Teikoku Hormone Mig. Co. Ltd.
-
Kobayashi M
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Natsume Tsugitaka
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Nakayama T
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Kawaguchi Motoko
Department Of Surgical Pathology Tokyo Women's Medical University
-
Kobayashi M
Department Of Public Health Social Medicine And Medical Informatics Ehime University Graduate School
-
Kobayashi M
Departments Of Pathology Tokyo Women
-
Watanabe Jun
Department Of Pathology School Of Medicine Kitasato University
-
Tsukagoshi S
Japanese Foundation For Cancer Res. Tokyo
-
Kobayashi Minatsu
Department Of Public Health Social Medicine And Medical Informatics Ehime University Graduate School
-
Fujio Nami
Drug Discovery Research Department Teikoku Hormone Mfg. Co. Ltd.
-
NATSUME Tsugitaka
ASKA Pharmaceutical Co., Ltd., Research & Development Division
-
KOBAYASHI Motohiro
ASKA Pharmaceutical Co., Ltd., Research & Development Division
-
Kobayashi Minatsu
Epidemiology And Prevention Division Research Center For Cancer Prevention And Screening National Ca
-
WATANABE Jun-ichi
Teikoku Hormone Mig. Co., Ltd.
-
TAMAOKI Satoru
Teikoku Hormone Mig. Co., Ltd.
-
FUJIO Nami
Teikoku Hormone Mig. Co., Ltd.
-
MIYASAKA Katsuhiko
Teikoku Hormone Mig. Co., Ltd.
-
KOBAYASHI Motohiro
Teikoku Hormone Mig. Co., Ltd.
-
Miyasaka Katsuhiko
Teikoku Hormone Mig. Co. Ltd.
-
Kobayashi Motohiro
Teikoku Hormone Mig. Co. Ltd.
著作論文
- Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma
- Characterization of the Interaction of TZT-1027, a Potent Antitumor Agent,with Tubulin